Articles
Established Brands: How Macro-Economic Factors Impacting Cash Flow for Large Pharma
Posted on August 2, 20228/2/22
COMPLETE Commercialization: Risk Management & Aligned Incentives
Posted on May 20, 20225/20/22
When A Curveball Threatens Your Product’s Launch
Posted on May 20, 20225/20/22
In this 3-minute video, Mike DeLaroche shares a new commercializing model that mitigates risk and combats curveballs that manufacturers cannot predict when launching products.
Driving Commercial Excellence for CAR-T
Posted on April 26, 20224/26/22
Faruk Abdullah, Head of U.S. Consulting, EVERSANA™ MANAGEMENT CONSULTING and Maria Kirsch, SVP & Head of Patient Services share insight on building the future commercialization model designed specifically for CAR-T.
Insights from Clients: Shorla Pharma emphasizes how specialty pharmacy is streamlining commercialization in an unpredictable market and maximizing brand value in the oncology space through valuable partnership.
Posted on February 16, 20222/16/22
Shorla Pharma emphasizes how specialty pharmacy is streamlining commercialization in an unpredictable market and maximizing brand value in the oncology space through valuable partnership. Watch the full interview with Bio Europe and Sharon Cunningham, CEO,…